ANTX
NASDAQ · Pharmaceuticals
An2 Therapeutics Inc
$5.93
-0.15 (-2.47%)
Open$6.13
Previous Close$6.08
Day High$6.18
Day Low$5.83
52W High$6.91
52W Low$1.00
Volume—
Avg Volume210.3K
Market Cap213.58M
P/E Ratio—
EPS$-1.10
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+212.8% upside
Current
$5.93
$5.93
Target
$18.55
$18.55
$11.23
$18.55 avg
$22.80
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.24M | 7.98M | 7.65M |
| Net Income | 1.80M | 1.81M | 1.71M |
| Profit Margin | 21.9% | 22.7% | 22.3% |
| EBITDA | 3.67M | 3.33M | 3.32M |
| Free Cash Flow | 1.39M | 970.9K | 896.1K |
| Rev Growth | -4.4% | +17.2% | +22.3% |
| Debt/Equity | 1.44 | 1.37 | 1.29 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |